Target intelligence / Profile preview

Apicoplast DNA polymerase (apPOL)

Target
apPOL
Molecular classification
Enzyme, DNA-directed DNA polymerase, A-family DNA polymerase
01

Overview

The apicoplast DNA polymerase (apPOL) is an essential enzyme in Plasmodium parasites, responsible for the replication and repair of the 35 kb circular genome within the apicoplast, a non-photosynthetic plastid organelle [1, 4]. As the sole DNA polymerase localized to this organelle, apPOL is a multitasking enzyme that performs both high-fidelity replicative synthesis and lesion bypass synthesis [12, 16]. It belongs to the A-family of DNA polymerases but is evolutionarily distinct from human polymerases, sharing closer homology with bacterial and cyanobacterial enzymes [1, 5]. Because the apicoplast is vital for the biosynthesis of essential metabolites like isoprenoids, heme, and fatty acids, inhibition of apPOL leads to the loss of the organelle and eventual parasite death [1, 11]. This process is often characterized by a "delayed death" phenotype, where the parasite survives one division cycle before succumbing [1, 2]. The lack of a direct human ortholog makes apPOL a highly attractive target for the development of novel antimalarial drugs, with small molecules like MMV666123 identified as potent and selective inhibitors [3, 9]. Structural studies using cryo-electron microscopy have revealed unique conformational changes and potential allosteric sites that could be exploited for drug design [4, 20].

Other names
apPolPOM1PfPREX polymerase domainPlastidic A-family DNA polymeraseDNA polymerase I-like protein
02

Mechanism of action

Inhibition of apicoplast DNA replication and repair, leading to the loss of the apicoplast organelle and subsequent parasite death.

03

Biological functions

DNA replicationDNA repairLesion bypass synthesis
04

Disease associations

MalariaInfection
05

Safety considerations

Selectivity over human mitochondrial DNA polymerase gammaDelayed death phenomenon
06

Interacting drugs

MMV666123
07

Biomarkers

Apicoplast-to-nucleus genome ratioIsoprenoid precursor levels

Beyond the preview

Go deeper on Apicoplast DNA polymerase (apPOL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apicoplast DNA polymerase (apPOL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call